You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 4, April 1958 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Studies in Experimental Ocular Tuberculosis

XVIII. The Effect of Cortisone Combined with Specific Antibacterial Therapy on Experimental Ocular Tuberculosis in the Immune-Allergic Rabbit

ALAN C. WOODS, M.D.; RONALD WOOD, Ph.D.; LAWRENCE B. SENTERFIT, Sc.D.

AMA Arch Ophthalmol. 1958;59(4):559-578.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

From 1948 to 1954 a series of papers on the effect of various antibacterial agents on experimental ocular tuberculosis appeared from the Wilmer Institute. These various studies have indicated that streptomycin is the one antibiotic thus far discovered with a strong antibacterial action against Mycobacterium tuberculosis. A number of the synthetics—glucosulfone (Promin), thiazosulfone (Promizole), aminosalicylic acid, and isoniazid—also have a specific antibacterial effect on the bacillus. This varies from a moderate bacteriostatic up to an actual bactericidal effect. It was further shown in these experimental studies that when streptomycin is used in combination with one of the synthetics as an adjuvant the antibacterial and therapeutic result is much greater than would be expected by a mere additive effect. It suggested a synergetic action of the two therapeutic agents. It was also shown that the use of these agents in combination inhibited to a considerable extent the development of bacterial resistance. . . . [Full Text PDF of this Article]


Author Affiliations

Baltimore


Footnotes

Received for publication July 15, 1957.

This investigation was supported by a grant from the National Institute of Neurology and Blindness, United States Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1958 American Medical Association. All Rights Reserved.